The ‘Doc’ is in: Assistance dog provides comfort to patients with cancer ‘He’s a good boy. And he brings people joy’: Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
OHSU uses bioelectric medicine in vagus nerve to help patients heal from stroke, arthritis October 01, 2026
OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol September 29, 2026
The ‘Doc’ is in: Assistance dog provides comfort to patients with cancer By Kari Hastings October 06, 2026 ‘He’s a good boy. And he brings people joy’: Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
OHSU uses bioelectric medicine in vagus nerve to help patients heal from stroke, arthritis By Erik Robinson October 01, 2026 Neurosurgeons are first in Oregon to implant devices that send small electrical pulses to stimulate healing, anti-inflammatory effect.
OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol By Erik Robinson September 29, 2026 One-time infusion using CRISPR may permanently lower LDL cholesterol, reducing the risk of heart attack, stroke.
OHSU ‘labor guide’ empowers patients, reduces risk during labor, delivery By Nicole Rideout September 24, 2026 New study shows low-cost strategy is effective against growing misinformation around childbirth, resistance to evidence-based care.
OHSU Doernbecher Children's Hospital celebrates 100 years of healing, innovation By OHSU News September 24, 2026 ‘In your worst moment, we’re at our best’: State’s first children’s hospital leads in groundbreaking research, pioneering treatments and compassionate, family-centered care.
PATHFINDER 2 findings advance multi-cancer early detection blood testing By Kari Hastings September 22, 2026 Blood test helps increase cancer detection 6.5-fold, identifies many cancers lacking routine screening options.
Intermittent fasting shows promise in slowing Huntington’s disease progression By Angela Yeager September 17, 2026 OHSU-led pilot study finds time-restricted eating is feasible, safe, linked to improvements in disease markers.
Clinical trial tests new way to treat common inherited heart disease By Erik Robinson August 28, 2026 OHSU investigator leads international clinical trial studying potential treatment for nonobstructive hypertrophic cardiomyopathy.
OHSU posts dramatic financial turnaround, record research funding By Sara Hottman July 29, 2026 Preliminary financial results show positive margin, more research grants from NIH, industry.